Pressure Grows on U.S. Companies to Share Covid Vaccine Technology September 22, 2021 Auto Bot Africa, Biden, Joseph R Jr, Coronavirus (2019-nCoV), Factories and Manufacturing, Intellectual Property, Moderna Inc, Pfizer Inc, Public-Private Sector Cooperation, Vaccination and Immunization 0 Moderna accepted $2.5 billion in taxpayer money to develop its Covid-19 vaccine. But officials in the U.S. and overseas are having trouble persuading the company to license its technology.